Press release
Companion Animal Vaccines Market Demand to Grow US$ 4,500 Mn by 2026
Zoetis Inc. will continue to account for a leading share of the US$ 2.26 Bn (2016) global companion animal vaccine market. The pharmaceutical company accounted for over 46% share of the global market in 2015, and it is expected to maintain its numero uno position during the forecast period 2016-2026. Merck & Co., Inc. and Merial, will remain the other key players in this market.Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1427
The key factors that will fuel demand for companion animal vaccines include,
Increasing trend of pet humanisation in developing countries
Adoption of pet vaccination programmes, such as 'herd immunity' and 'One Health'
Increasing emphasis on preventing and detecting avian flu
Rising pet insurance rates in the U.S. and other developed countries
Awareness on the benefits of preventive healthcare over reactive healthcare
Collaboration among leading pharmaceutical manufacturers for research and development.
According to Future Market Insights' research, lack of information on emerging virulent veterinary diseases, and decline sales revenues through veterinarians can stifle demand for companion animal vaccines during the forecast period. The longstanding challenges with correctly identifying and understanding antigen/immunogenic structures can also negatively impact the growth of the market.
Nearly US$ 764 Mn worth of attenuated live vaccines were sold globally in 2016. This segment is projected to grow at a CAGR of 7.3% during the forecast period 2016-2026.
Request for Table of Contents @ https://www.futuremarketinsights.com/toc/rep-gb-1427
Distribution Channel Analysis: Veterinary Clinics will Remain the Preferred Distribution Channel
Veterinary clinics continue to be the preferred distribution channel for pharma companies, followed by veterinary hospitals. These two point of care centres witness substantial footfall of pet owners all year round, and drug companies continuously focus on increasing sales through these channels. In 2016, these two distribution channels collectively accounted for nearly 75% revenue share of the market. By the end of forecast period, the status quo is expected to remain unchanged. Retail pharmacies, which held 20% share of the market in 2016, will grow at the highest CAGR during the forecast period.
North America - Largest Market for Companion Animal Vaccines
The U.S. continues to be a leading market for companion animal vaccines. High level of awareness among pet owners, combined with easy availability of pet healthcare have resulted into the growth of the market in the U.S. On account of strong demand in the U.S., North America will continue to be the largest market globally.
The North America companion animals market was valued at nearly US$ 676 in 2016. It is projected to increase at 6.9% CAGR through 2026, reaching over US$ 1.3 Bn in revenues. Western Europe, the second-largest market for companion animal vaccines is projected to grow at 7.1% CAGR through 2026.
Buy Companion Animal Vaccines Market Research Report @ https://www.futuremarketinsights.com/checkout/1427
ABOUT US
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
CONTACT
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Companion Animal Vaccines Market Demand to Grow US$ 4,500 Mn by 2026 here
News-ID: 830477 • Views: …
More Releases from Future Market Insights

External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,…

External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,…

External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,…

External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,…
More Releases for Companion
Companion Animal Medicine Market Healthy Companions, Healthy Profits: Trends in …
Companion Animal Medicine Market to reach over USD 41.71 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Medicine Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats, And Horses), Product (Pharmaceuticals And Medicated Feed Additives), Distribution Channel (Veterinary Hospitals And Clinics), And Indication (Antibiotics and Parasiticides)- Market Outlook…
Companion Diagnostics Market - Companion Diagnostics Industry Size, Share, Analy …
Companion diagnostics are medical devices and tests that provide essential information for the safe and effective use of a corresponding drug or biological product. These diagnostics are critical in the field of personalized medicine, as they help identify patients who are most likely to benefit from a particular therapeutic product. The Global Companion Diagnostics Market was valued at US$ 5.59 Billion in 2022 and is projected to reach US$ 13.74…
Companion Animal Digital Technology Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Digital Technology Market By Type of Service (Telemedicine, Telehealth, Reminder Applications, Trackers, Wearables, and Platform Market Places) Trends, Industry Competition Analysis, COVID-19 Impact Analysis, Revenue and Forecast Till 2031." features detailed market analysis and an extensive study on the current trends, exploring its significant factors.
The Artificial Intelligence (AI) In Beauty and Cosmetics Market…
Companion Diagnostics Market - Transforming Patient Outcomes: Pioneering Compani …
Newark, New Castle, USA: The "Companion Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Companion Diagnostics Market: https://www.growthplusreports.com/report/companion-diagnostics-market/8673
This latest report researches the industry structure, sales, revenue,…
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S.
Moreover, the…
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test…